Gallagher Kathleen P. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Gallagher Kathleen P.（CIK 2048409）在 2 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-09-22）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-22 | Atrium Therapeutics, Inc. (RNA) | Chief Executive Officer and President | 卖出 | 11,632 | $104,106 |
| 2026-04-22 | Atrium Therapeutics, Inc. (RNA) | Chief Executive Officer and President | 买入 | 102,500 | $0 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Chief Program Officer | 卖出 | 80,303 | $0 |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 买入 | 72,000 | $0 |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 卖出 | 33,336 | $2.4M |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 卖出 | 8,030 | $577,116 |
| 2025-09-02 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 卖出 | 188 | $8,915 |
| 2025-06-18 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 卖出 | 911 | $27,549 |
| 2025-06-04 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 买入 | 5,875 | $97,819 |
| 2025-06-04 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 卖出 | 5,875 | $190,820 |
| 2025-05-02 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 买入 | 5,875 | $97,819 |
| 2025-05-02 | Avidity Biosciences, Inc. (RNA) | Chief Program Officer | 卖出 | 5,875 | $190,350 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22